China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

Market Cap	48.06B -14.8%
Revenue (ttm)	31.63B +14.5%
Net Income	3.42B +1.6%
EPS	2.06 +1.8%
Shares Out	1.66B
PE Ratio	14.02
Forward PE	13.04
Dividend	0.70 (2.44%)
Ex-Dividend Date	Oct 17, 2025

Volume	9,485,896
Average Volume	15,089,272
Open	28.74
Previous Close	28.71
Day's Range	28.58 - 28.93
52-Week Range	27.65 - 35.36
Beta	0.22
RSI	53.26
Earnings Date	Mar 21, 2026

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chinese ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 20,031
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2025, SHE:000999's revenue was 31.63 billion, an increase of 14.53% compared to the previous year's 27.62 billion. Earnings were 3.42 billion, an increase of 1.60%.